CureVac Lobs Infringement Counterclaims At BioNTech, Pfizer
CureVac on Friday accused BioNTech and Pfizer of infringing nine of its patents covering COVID-19 technology, lodging counterclaims in the pharmaceutical companies' case, which was recently transferred from Massachusetts to Virginia...To view the full article, register now.
Already a subscriber? Click here to view full article